Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial

OBJECTIVE: This research aims to evaluate the preclinical meritorious and anticancer effects of Metformin in a Xenograft model of breast cancer. METHODS: This interventional trial was conducted during a defined period of 5 months (August 2016 January 2017). We used a Xenograft model of nude BALB/c m...

Descripción completa

Detalles Bibliográficos
Autores principales: Rizvi, Fatima, Shaukat, Lubna, Azhar, Arfa, Jafri, Alia, Aslam, Unum, Imran-ul-Haq, Hafiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taibah University 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348326/
https://www.ncbi.nlm.nih.gov/pubmed/34408607
http://dx.doi.org/10.1016/j.jtumed.2021.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348326/
https://www.ncbi.nlm.nih.gov/pubmed/34408607
http://dx.doi.org/10.1016/j.jtumed.2021.02.006

Ejemplares similares